Clara Jeou Jen Lin

This inventor holds 14 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 9 EPO patents. Top assignees: Roche Palo Alto LLC, Hoffmann-La Roche Inc., Syntex (u.s.a.) Inc.. Active years: 2001-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clara Jeou Jen Lin. Retrieved from https://idiyas.com/inventor/clara-jeou-jen-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 10)

% Patents Active = 57.1

CIPO Patents = 1

EPO Patents = 9 (Patent Applications = 7)

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 56(Granted Patents)

Company Filing History:

Hoffmann-La Roche Inc.

where one patent can have more than one assignee

Years Active: 2001-2018

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10023589 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators (2018-07-17),

2. 9556127 - [object Object] (2017-01-31),

3. 9255110 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators (2016-02-09),

4. 8846705 - [object Object] (2014-09-30),

5. 8513425 - Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof (2013-08-20),

6. 8084623 - Pyrrolidinyl and piperidinyl ketone derivatives and uses thereof (2011-12-27),

7. 8071797 - Heterocyclic antiviral compounds (2011-12-06),

8. 7858632 - [object Object] (2010-12-28),

9. 7799796 - [object Object] (2010-09-21),

10. 7491821 - [object Object] (2009-02-17),

11. 7407980 - Imidazolinylmethyl aralkylsulfonamides (2008-08-05),

12. 6979696 - Method for detecting a gram-negative bacterial autoinducer molecule (2005-12-27),

13. 6756395 - Imidazolinyimethyl aralklsulfonamides (2004-06-29),

14. 6319920 - 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives (2001-11-20),

Title: Clara Jeou Jen Lin: A Pioneer in Pharmaceutical Innovations

Introduction

Clara Jeou Jen Lin, located in Palo Alto, California, is a notable inventor recognized for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 14 patents, her work is focused on developing innovative compounds that have the potential to transform the treatment of various health conditions.

Latest Patents

Among her latest inventions, Lin has developed pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators. These compounds, characterized by specific structural formulas, are designed for the treatment of IRAK-mediated conditions. Additionally, she has produced novel compounds and methods for treating diseases mediated by P2X receptors, comprising the administration of effective amounts of a compound that can include pharmaceutically acceptable salts or prodrugs.

Career Highlights

Lin's impressive career includes tenures at Roche Palo Alto LLC and Hoffmann-La Roche Inc., leading her to contribute to pioneering pharmaceutical research. Her dedication and expertise have positioned her as a leading figure in her domain, with a clear focus on advancing medical treatments through innovative chemical compounds.

Collaborations

Throughout her career, Lin has collaborated with notable individuals such as Michael Patrick Dillon and Alam Jahangir. These partnerships have helped bolster her research and development efforts, contributing to the production of patents that stand to make a significant impact in the medical field.

Conclusion

Clara Jeou Jen Lin exemplifies the spirit of innovation through her valuable contributions to patentable inventions in the pharmaceutical industry. Her work not only highlights her prowess as an inventor but also underscores the importance of collaboration in driving forward advancements that can lead to improved healthcare solutions.

Profile summary based on public USPTO records.